REGENERON PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 2314000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2010-12-31) |
| Status | current |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:06.709867+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2795ad7e-6076-4f22-830c-aac669940186
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001206774-12-000709Retrieved: 2026-08-19T08:39:06.709867+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/accounts-receivable/2010-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2795ad7e-6076-4f22-830c-aac669940186
History
- supersedes {"amount": 13509000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} (evidence 0001206774-11-000263)